Taurus Asset Management LLC Purchases 6,500 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Taurus Asset Management LLC raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 188,200 shares of the medical device company's stock after acquiring an additional 6,500 shares during the quarter. Cooper Companies comprises approximately 1.7% of Taurus Asset Management LLC's holdings, making the stock its 26th largest position. Taurus Asset Management LLC owned about 0.09% of Cooper Companies worth $17,301,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. JPMorgan Chase & Co. lifted its position in shares of Cooper Companies by 1.5% in the 4th quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock worth $460,066,000 after acquiring an additional 74,501 shares during the period. Geode Capital Management LLC grew its stake in Cooper Companies by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock worth $449,907,000 after buying an additional 109,907 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after purchasing an additional 574,899 shares in the last quarter. Norges Bank acquired a new position in Cooper Companies during the 4th quarter worth $217,906,000. Finally, FMR LLC grew its stake in shares of Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after purchasing an additional 1,095,805 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on COO shares. Robert W. Baird lowered their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Stifel Nicolaus lowered their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Stock Performance

Cooper Companies stock traded up $1.28 during trading hours on Friday, hitting $79.51. The company had a trading volume of 2,096,454 shares, compared to its average volume of 1,409,723. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The firm has a 50-day moving average of $83.34 and a 200 day moving average of $93.87. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $15.90 billion, a PE ratio of 40.77, a PEG ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.